Nano Labs 6-K adds unaudited 2025 financials

Nano Labs Ltd filed a Form 6-K as a foreign private issuer for September 2025.

Rhea-AI Filing Summary

Nano Labs Ltd filed a Form 6-K as a foreign private issuer for September 2025. The filing furnishes unaudited consolidated financial statements as of December 31, 2024 and June 30, 2025, along with results for the six months ended June 30, 2024 and 2025.

The 6-K also includes management’s discussion and analysis of financial condition and results of operations, and incorporates these materials by reference into three existing Form F-3 registration statements previously filed with the U.S. Securities and Exchange Commission.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Nano Labs Ltd (NA) report in this September 2025 Form 6-K?

Nano Labs Ltd furnishes a Form 6-K providing unaudited consolidated financial statements and management’s discussion and analysis. These materials cover financial positions at December 31, 2024 and June 30, 2025, and results for the six months ended June 30, 2024 and 2025.

Which financial periods are covered in Nano Labs Ltd (NA) unaudited statements?

The unaudited consolidated financial statements cover Nano Labs Ltd’s financial position as of December 31, 2024 and June 30, 2025. They also present results for the six months ended June 30, 2024 and the six months ended June 30, 2025, giving mid‑year comparative information.

What additional analysis accompanies Nano Labs Ltd (NA) financial statements in the 6-K?

Alongside the unaudited financial statements, Nano Labs Ltd includes management’s discussion and analysis of financial condition and results of operations. This narrative section explains key aspects of the company’s financial position and performance over the covered periods for investors and analysts.

How is this Nano Labs Ltd (NA) 6-K linked to its Form F-3 registrations?

The 6-K explicitly incorporates exhibits 99.1 and 99.2 by reference into three Form F-3 registration statements. These are Registration Nos. 333-273968, 333-288573, and 333-289211, making the newly furnished financials and analysis part of those shelf registration documents.

Who signed Nano Labs Ltd (NA) September 2025 Form 6-K filing?

The Form 6-K was signed on behalf of Nano Labs Ltd by Jianping Kong, who is identified as Chairman and Chief Executive Officer. This signature confirms the company’s authorization of the furnished financial statements and management analysis contained in the exhibits.

What exhibits are included with Nano Labs Ltd (NA) September 2025 Form 6-K?

Key exhibits include 99.1, the unaudited consolidated financial statements, and 99.2, management’s discussion and analysis. Additional exhibits are Inline XBRL files, including instance, schema, calculation, definition, label, and presentation linkbase documents supporting structured financial data reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/17/2025 - 08:23 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

 Commission File Number: 001-41426

Nano Labs Ltd

(Exact name of registrant as specified in its charter)

China Yuangu Hanggang Technology Building

509 Qianjiang Road, Shangcheng District,

Hangzhou, Zhejiang, 310000

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒         Form 40-F ☐

EXPLANATORY NOTE

The documents attached as exhibits 99.1 and 99.2 to this Form 6-K are hereby incorporated by reference into the registrant’s Registration Statements on (1) Form F-3 initially filed with the U.S. Securities and Exchange Commission (the “Commission”) on August 14, 2023 (Registration No. 333-273968), (2) Form F-3, as amended, initially filed with the Commission on July 9, 2025 (Registration No. 333-288573), and (3) Form F-3, as amended, initially filed with the Commission on August 4, 2025 (Registration No. 333-289211), and shall be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Nano Labs Ltd
Date: September 17, 2025	By:	/s/ Jianping Kong
	Name:	Jianping Kong
	Title:	Chairman and Chief Executive Officer

2

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		Unaudited Consolidated Financial Statements as of December 31, 2024 and June 30, 2025 and for the six months ended June 30, 2024 and 2025
Exhibit 99.2		Management’s Discussion and Analysis of Financial Condition and Results of Operations
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document

3